Connect with us:

News from Blythedale

Blythedale Names New CMO


Scott Klein, Formerly of Maimonides, VNSNY, Joins Leadership Team at New York’s Only Specialty Children’s Hospital

(VALHALLA, NY – May 13, 2013) – Blythedale Children’s Hospital, New York’s only specialty children’s hospital, has named Scott M. Klein, MD, MHSA, its new Chief Medical Officer and Chief of Pediatrics, Blythedale President and CEO Larry Levine announced today.  

Klein, 43, of Roslyn, Long Island, comes to Blythedale with 10 years of experience at Maimonides Infant’s and Children’s Hospital in Brooklyn, where he served as Vice Chairman of Clinical Services, Associate Medical Director and Director of the Pediatric Critical Care Unit.  For the past two years, he served as Chief Medical Officer for Hospice and Palliative Care at the Visiting Nurse Service of New York.

"Blythedale is at a very exciting point in its history, and we are thrilled to welcome Scott Klein on board,” said Levine.  "Dr. Klein brings a unique skill set and understanding of the delivery of pediatric specialty care that will enable us to set the standard for how care is delivered to medically fragile children. He brings a high level of compassion and a deep understanding of what it takes to work with some of the New York metropolitan area’s most vulnerable patients. At Blythedale, he joins a dedicated team of board-certified physicians, nurses and therapists with wide-ranging pediatric expertise.”

Blythedale opened a new $65.3 million, 86-bed, 56,000-square-foot inpatient building in December 2011, featuring an Infant, Toddler and Post-Neonatal and Pediatric Intensive Care Unit, a dedicated Traumatic Brain Injury (TBI) Unit, a Pediatric and Adolescent Inpatient Unit and Family Resource Center.
Board certified in Pediatrics, Pediatric Critical Care Medicine and Pediatric Hospice and Palliative Care Medicine, Klein views himself as a strong advocate for children and their families as they face difficult medical situations.

"The children we care for at Blythedale are the most medically fragile patients – children with severe respiratory conditions, congenital heart ailments, traumatic brain injuries, severe burns and a host of other injuries or illnesses,” Klein said. "Both they and their families are facing a very difficult path. It is our responsibility to deliver the highest levels of quality healthcare and medical rehabilitation services to help them recover as best and as quickly as possible and look forward to the lives ahead of them.”

Klein will replace Dr. Joelle Mast, who will become Blythedale’s Chief Science Officer, responsible for expanding the hospital’s research program into a nationally-recognized research institute.

"Dr. Mast has played a vital role in Blythedale’s growth over the last two decades,” said Levine.  "As we continue to expand our research capabilities, we are very fortunate that she will be leading our research team and overseeing projects that can have a tremendous impact on the lives of medically fragile children.” 

Klein received his medical degree from the Medical College of Pennsylvania, which is now Drexel University College of Medicine. He also received a Masters of Health Services Administration from University of Michigan School of Public Health.  He is married and has twin daughters. 
Patient Stories
Story Picture
Twins Kassius and Keaton were born in June, 2015, at just 30-weeks gestation
Latest News
11-29-17 - Long Term Care... and Going Home
A Message from Larry Levine, President & CEO of...

06-05-17 - In the Blink of an Eye
A Message from Larry Levine, President & CEO of...

04-02-18 - Components of Movement & the Principles of Neurodevelopmental Treatment (NDT) with Lois Bly

In the Spotlight